The US Food and Drug Administration (FDA) has granted 510(k) approval to Smiths Medical’s multi-therapy ambulatory infusion system.
Featuring five delivery modes, step, taper, continuous, intermittent and patient-controlled analgesia (PCA), the CADD-Solis variable infusion profile (VIP) ambulatory infusion system provides reliable and safe infusion delivery for home care patients.
The infusion system, which features an ambulatory infusion pump attached to medication cassette reservoirs and administration sets, is designed for use in various therapies including total parenteral nutrition, chemotherapy, antibiotics, hydration, pain management and intravenous / subcutaneous immunoglobulin infusions for adult and pediatric patients.
Holding up to 500 protocols and pharmacist-defined soft and hard limits, the pump’s therapy-specific colour screens easily differentiate each delivery mode and provide intuitive, easy-to-use navigation.
The VIP system also features medication safety software allowing home care pharmacists to enter, store and download custom therapy-based protocols to the pump, and will alert operators or interrupt the infusion process when a pump setting is programmed outside of preconfigured limits.
The software also enables clinicians to view reports on infusion data and delivery history for quick and easy therapy assessment and continuous quality improvement, according to the US-based medical device company.
Smiths Medical president Srini Seshadri said; "We are extremely pleased to be able to continue that tradition with a smart, innovative new system that will help home care providers to prevent pump programming errors and improve patient safety."
The company said that the multi-therapy system is available for sale in Canada, France, Germany, Switzerland, the Netherlands, Australia, the UK and the Middle East.
Image: The multi-therapy infusion system provides reliable and safe infusion delivery for home care patients. Photo: Courtesy of Smiths Medical.